BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2921777)

  • 1. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis.
    Kovacs G; Wilkens L; Papp T; de Riese W
    J Natl Cancer Inst; 1989 Apr; 81(7):527-30. PubMed ID: 2921777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes.
    Hughson MD; Meloni A; Dougherty S; Silva FG; Sandberg AA
    Cancer Genet Cytogenet; 1996 Apr; 87(2):133-9. PubMed ID: 8625259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic findings in renal cell carcinoma.
    Iqbal MA; Akhtar M; Ali MA
    Hum Pathol; 1996 Sep; 27(9):949-54. PubMed ID: 8816891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed microsatellite analysis of chromosome 3p region in non-papillary renal cell carcinomas.
    Chudek J; Wilhelm M; Bugert P; Herbers J; Kovacs G
    Int J Cancer; 1997 Oct; 73(2):225-9. PubMed ID: 9335447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
    Wilhelm M; Bugert P; Kenck C; Staehler G; Kovacs G
    Cancer Res; 1995 Nov; 55(22):5383-5. PubMed ID: 7585605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
    Hughson MD; Johnson LD; Silva FG; Kovacs G
    Mod Pathol; 1993 Jul; 6(4):449-56. PubMed ID: 8415591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
    Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
    Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.
    Thrash-Bingham CA; Greenberg RE; Howard S; Bruzel A; Bremer M; Goll A; Salazar H; Freed JJ; Tartof KD
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2854-8. PubMed ID: 7708737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
    Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
    J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
    Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
    Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy.
    Corless CL; Aburatani H; Fletcher JA; Housman DE; Amin MB; Weinberg DS
    Diagn Mol Pathol; 1996 Mar; 5(1):53-64. PubMed ID: 8919546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microsatellite analysis of the 3p13-p25 region in renal cell carcinoma in humans].
    Aliaga M; Millán Salvador JM; Jiménez Cruz JF
    Actas Urol Esp; 2002 Mar; 26(3):150-62. PubMed ID: 12053515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
    Sükösd F; Kuroda N; Beothe T; Kaur AP; Kovacs G
    Cancer Res; 2003 Jan; 63(2):455-7. PubMed ID: 12543802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p.
    Füzesi L; Gunawan B; Bergmann F; Tack S; Braun S; Jakse G
    Histopathology; 1999 Aug; 35(2):157-61. PubMed ID: 10460661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.
    Hadaczek P; Podolski J; Toloczko A; Kurzawski G; Sikorski A; Rabbitts P; Huebner K; Lubinski J
    Virchows Arch; 1996 Sep; 429(1):37-42. PubMed ID: 8865851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma.
    Wu SQ; Hafez GR; Xing W; Newton M; Chen XR; Messing E
    Cancer; 1996 Mar; 77(6):1154-60. PubMed ID: 8635138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.